63
Views
9
CrossRef citations to date
0
Altmetric
Case Reports

Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy

, , , &
Pages 155-157 | Received 11 Nov 2003, Accepted 17 Dec 2003, Published online: 11 Mar 2010

References

  • Whimbey E, Englund JA, Couch RB. Community respiratory virus infection in immunocompromized patients with cancer. Am J Med 1997; 102: 10–8.
  • Small TN, Casson A, Malak SF, Boulad F, Keihn TE, Stices J, et al. Respiratory syncytial virus infection following haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 321–7.
  • Hassan IA, Chopra R, Swindell R, Mutton KJ. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie Hospital experience. Bone Marrow Transplant 2003; 32: 73–7.
  • Harrington RD, Hooton TM, Hackman RC, Storch CA, Osborne B, Gleaves GA, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant centre. J Infect Dis 1992; 165: 987–93.
  • Bowden RA. Respiratory virus infections after marrow transplantation: the Fred Hutchinson Cancer Center research experience. Am J Med 1997; 102: 27–30.
  • Whimbey E, Champlin RE, Englund JA, Hirza NO, Peidra PA, Goodrich JM, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 393–9.
  • Couch RB, England JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromized persons. Am J Med 1997; 102: 2–9.
  • Ghosh S, Champlin RE, Englund J, Gralt SA, Rolston K, Raad I, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult bone and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751–5.
  • McCarthy AJ, Kingman HM, Kelly C, Taylor GS, Caul EO, Grier D, et al. The outcome of 26 patients with respiratory syncitial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 1315–22.
  • Ottolini MG, Curtis SR, Mathews A, Ottolini SR, Prince GA. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplant 2002; 29: 117–20.
  • Boeckh M, Berrey MM, Bowden RA, Crawford SW, Balsley J, Corey L. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of haematopoietic stem cells transplants. J Infect Dis 2001; 184: 350–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.